Get the app
US › Healthcare

Pulmatrix Inc (PULM)

US · Healthcare · Biotechnology

$1.36-3.55%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-1.0M
EPS
$-0.29

Key statistics

Market cap
$5.0M
Forward P/E
0.0
P/B
3.87
Book value
$0.44
EPS (TTM)
$-1.10
52-week high
$5.24
52-week low
$1.16
50-day MA
$1.51
200-day MA
$1.75
Beta
1.93

Analyst view

with an average price target of $10.00.

Shareholding

Insiders
0.78%
Institutions
9.16%

Largest institutional holders

FundStake
Renaissance Technologies Corp3.36%
BlackRock Inc1.50%
Geode Capital Management, LLC0.91%
Vanguard Capital Management, LLC0.88%
SBI Securities Co Ltd0.86%
Shay Capital LLC0.52%
Vanguard Fiduciary Trust Co0.40%
State Street Corp0.38%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Pulmatrix Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.